Hyperdense middle cerebral artery sign and outcome after intravenous thrombolysis for acute ischemic stroke

Journal of the Neurological Sciences

Volumn 285, Issue 1-2, 2009, Pages 114-117

  Aries, M J H ^a   Uyttenboogaart, M ^a   Koopman, K ^a   Rodiger L A ^a   Vroomen, P C ^a   De Keyser, J ^a,b   Luijckx, G J ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b UNIVERSITY HOSPITAL BRUSSELS   (Belgium)

Author keywords

Hyperdense middle cerebral artery sign; Ischemic stroke; Outcome; Symptomatic intracranial hemorrhage; Thrombolysis; tPA treatment

Indexed keywords

TISSUE PLASMINOGEN ACTIVATOR;

AGED; ARTICLE; BLOOD CLOT LYSIS; BRAIN CIRCULATION; CEREBROVASCULAR ACCIDENT; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; FEMALE; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MEDICAL PRACTICE; MIDDLE CEREBRAL ARTERY; PRIORITY JOURNAL;

ACUTE DISEASE; AGED; BRAIN; BRAIN INFARCTION; BRAIN ISCHEMIA; FEMALE; FIBRINOLYTIC AGENTS; FOLLOW-UP STUDIES; HUMANS; INFUSIONS, INTRAVENOUS; MALE; MIDDLE CEREBRAL ARTERY; RECOMBINANT PROTEINS; REGISTRIES; STROKE; THROMBOLYTIC THERAPY; TIME FACTORS; TISSUE PLASMINOGEN ACTIVATOR; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME;

EID: 69549091697     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jns.2009.06.010     Document Type: Article

References (21)

1. Leys D., Pruvo J.P., Godefroy O., Rondepierre P., and Leclerc X. Prevalence and significance of hyperdense middle cerebral artery in acute stroke. Stroke 23 3 (1992) 317-324
2. Tomsick T., Brott T., Barsan W., Broderick J., Haley E.C., Spiker J., et al. Prognostic value of the hyperdense middle cerebral artery sign and stroke scale score before ultraearly thrombolytic therapy. AJNR Am J Neuroradiol 17 1 (1996) 79-85
3. Manelfe C., Larrue V., von Kummer R., Bozzao L., Ringleb P., Bastianello S., et al. Association of hyperdense middle cerebral artery sign with clinical outcome in patients treated with tissue plasminogen activator. Stroke 30 4 (1999) 769-772
4. Qureshi A.I., Ezzeddine M.A., Nasar A., Suri M.F., Kirmani J.F., Janjua N., et al. Is IV tissue plasminogen activator beneficial in patients with hyperdense artery sign?. Neurology 66 8 (2006) 1171-1174
5. Wahlgren N., Ahmed N., Davalos A., Ford G.A., Grond M., Hacke W., et al. Thrombolysis with alteplase for acute ischaemic stroke in the Safe Implementation of Thrombolysis in Stroke-Monitoring Study (SITS-MOST): an observational study. Lancet 369 9558 (2007) 275-282
6. Kharitonova T., Ahmed N., Thoren M., Wardlaw J.M., von Kummer R., Glahn J., et al. Hyperdense middle cerebral artery sign on admission CT scan-prognostic significance for ischaemic stroke patients treated with intravenous thrombolysis in the safe implementation of thrombolysis in Stroke International Stroke Thrombolysis Register. Cerebrovasc Dis 27 1 (2008) 51-59
7. Uyttenboogaart M., Vroomen P.C., Stewart R.E., De Keyser J., and Luijckx G.J. Safety of routine IV thrombolysis between 3 and 4.5 h after ischemic stroke. J Neurol Sci 254 1-2 (2007) 28-32
8. Tissue plasminogen activator for acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. N Engl J Med 1995; 333 (24): 1581-7.
9. Hacke W., Kaste M., Fieschi C., von Kummer R., Davalos A., Meier D., et al. Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II). Second European-Australasian Acute Stroke Study Investigators. Lancet 352 9136 (1998) 1245-1251
10. Bamford J., Sandercock P., Dennis M., Burn J., and Warlow C. Classification and natural history of clinically identifiable subtypes of cerebral infarction. Lancet 337 8756 (1991) 1521-1526
11. Patel S.C., Levine S.R., Tilley B.C., Grotta J.C., Lu M., Frankel M., et al. Lack of clinical significance of early ischemic changes on computed tomography in acute stroke. JAMA 286 22 (2001) 2830-2838
12. Dohoo I.R., Ducrot C., Fourichon C., Donald A., and Hurnik D. An overview of techniques for dealing with large numbers of independent variables in epidemiologic studies. Prev Vet Med 29 3 (1997) 221-239
13. Bastianello S., Pierallini A., Colonnese C., Brughitta G., Angeloni U., Antonelli M., et al. Hyperdense middle cerebral artery CT sign. Comparison with angiography in the acute phase of ischemic supratentorial infarction. Neuroradiology 33 3 (1991) 207-211
14. Wardlaw J.M., and Mielke O. Early signs of brain infarction at CT: observer reliability and outcome after thrombolytic treatment-systematic review. Radiology 235 2 (2005) 444-453
15. Tomsick T., Brott T., Barsan W., Broderick J., Haley E.C., and Spilker J. Thrombus localization with emergency cerebral CT. AJNR Am J Neuroradiol 13 1 (1992) 257-263
16. Agarwal P., Kumar S., Hariharan S., Hariharan S., Eshkar N., Verro P., et al. Hyperdense middle cerebral artery sign: can it be used to select intra-arterial versus intravenous thrombolysis in acute ischemic stroke?. Cerebrovasc Dis 17 2-3 (2004) 182-190
17. Gacs G., Fox A.J., Barnett H.J., and Vinuela F. CT visualization of intracranial arterial thromboembolism. Stroke 14 5 (1983) 756-762
18. Von Kummer R., Meyding-Lamade U., Forsting M., Rosin L., Rieke K., Hacke W., et al. Sensitivity and prognostic value of early CT in occlusion of the middle cerebral artery trunk. AJNR Am J Neuroradiol 15 1 (1994) 9-15
19. Roberts H.C., Dillon W.P., Furlan A.J., Wechsler L.R., Rowley H.A., Fischbein N.J., et al. Computed tomographic findings in patients undergoing intra-arterial thrombolysis for acute ischemic stroke due to middle cerebral artery occlusion: results from the PROACT II trial. Stroke 33 6 (2002) 1557-1565
20. Mattle H.P., Arnold M., Georgiadis D., Baumann C., Nedeltchev K., Benninger D., et al. Comparison of intraarterial and intravenous thrombolysis for ischemic stroke with hyperdense middle cerebral artery sign. Stroke 39 2 (2008) 379-383
21. Barber P.A., Demchuk A.M., Zhang J., and Buchan A.M. Validity and reliability of a quantitative computed tomography score in predicting outcome of hyperacute stroke before thrombolytic therapy. ASPECTS Study Group. Alberta Stroke Programme Early CT Score. Lancet 355 2 (2000) 1670-1674 [Erratum: Lancet 2000;355:2170.]